SureScan Post-Approval Study
1 other identifier
observational
2,483
2 countries
61
Brief Summary
The purpose of this Post-Approval Study (PAS) is to demonstrate the chronic performance of the SureScan pacing system when used in an MRI environment according to product labeling. This study is required by the Food and Drug Administration (FDA) as a condition of product approval.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2011
Longer than P75 for all trials
61 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2011
CompletedFirst Submitted
Initial submission to the registry
February 16, 2011
CompletedFirst Posted
Study publicly available on registry
February 18, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2017
CompletedApril 27, 2018
April 1, 2018
6.7 years
February 16, 2011
April 26, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MRI Related Complication Rate
5 years
Lead Related Complication Rate
5 years
Secondary Outcomes (4)
Assess change in pacing thresholds after multiple MRI scans
5 years
Summarize MRI system and scan conditions
5 years
Pacing system related events
5 years
Characterize lead impedance
5 years
Study Arms (2)
Chronic Performance
Subjects enrolled prior to or within 30 days post implant of SureScan pacing system. In office follow-up visits required every 6 months.
Multiple MRI Scan Characterization
Subject enrolled into study at the time of MRI Scan indication. Subject followed per clinic standard of care.
Eligibility Criteria
Patients indicated for or implanted with a Medtronic SureScan Pacing System. All subjects must meet Inclusion criteria and none of the Exclusion criteria.
You may qualify if:
- Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Subject is or intended to be implanted with a complete SureScan pacing system consisting of both a right atrial and ventricular 5086MRI Lead (used for pacing and sensing) and a SureScan device
- Subject within 30 days of implant (maximum 50% of Chronic Performance Arm enrollment) or subject enrolled into Multiple MRI Scan Arm at the time of MRI scan indication
You may not qualify if:
- Subject who is, or will be inaccessible for follow-up
- Implant and follow-up data, including adverse device effects and system modifications at implant through the time of enrollment are unavailable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medtroniclead
Study Sites (61)
Unknown Facility
Little Rock, Arkansas, United States
Unknown Facility
Bakersfield, California, United States
Unknown Facility
Chula Vista, California, United States
Unknown Facility
East Palo Alto, California, United States
Unknown Facility
Fresno, California, United States
Unknown Facility
Glendale, California, United States
Unknown Facility
Long Beach, California, United States
Unknown Facility
Los Angeles, California, United States
Unknown Facility
Salinas, California, United States
Unknown Facility
Santa Rosa, California, United States
Unknown Facility
Torrance, California, United States
Unknown Facility
Van Nuys, California, United States
Unknown Facility
Colorado Springs, Colorado, United States
Unknown Facility
New Haven, Connecticut, United States
Unknown Facility
Bradenton, Florida, United States
Unknown Facility
Clearwater, Florida, United States
Unknown Facility
Fort Lauderdale, Florida, United States
Unknown Facility
Atlanta, Georgia, United States
Unknown Facility
Urbana, Illinois, United States
Unknown Facility
Evansville, Indiana, United States
Unknown Facility
West Des Moines, Iowa, United States
Unknown Facility
Kansas City, Kansas, United States
Unknown Facility
Louisville, Kentucky, United States
Unknown Facility
Salisbury, Maryland, United States
Unknown Facility
Takoma Park, Maryland, United States
Unknown Facility
Marquette, Michigan, United States
Unknown Facility
Troy, Michigan, United States
Unknown Facility
Coon Rapids, Minnesota, United States
Unknown Facility
Robbinsdale, Minnesota, United States
Unknown Facility
Saint Louis Park, Minnesota, United States
Unknown Facility
Saint Paul, Minnesota, United States
Unknown Facility
Kansas City, Missouri, United States
Unknown Facility
Henderson, Nevada, United States
Unknown Facility
West Orange, New Jersey, United States
Unknown Facility
Albuquerque, New Mexico, United States
Unknown Facility
Huntington, New York, United States
Unknown Facility
New York, New York, United States
Unknown Facility
Durham, North Carolina, United States
Unknown Facility
Hickory, North Carolina, United States
Unknown Facility
Raleigh, North Carolina, United States
Unknown Facility
Winston-Salem, North Carolina, United States
Unknown Facility
Akron, Ohio, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Cleveland, Ohio, United States
Unknown Facility
Columbus, Ohio, United States
Unknown Facility
Elyria, Ohio, United States
Unknown Facility
Toledo, Ohio, United States
Unknown Facility
Bethlehem, Pennsylvania, United States
Unknown Facility
Erie, Pennsylvania, United States
Unknown Facility
Lancaster, Pennsylvania, United States
Unknown Facility
Wyomissing, Pennsylvania, United States
Unknown Facility
Florence, South Carolina, United States
Unknown Facility
Nashville, Tennessee, United States
Unknown Facility
Dallas, Texas, United States
Unknown Facility
Fort Sam Houston, Texas, United States
Unknown Facility
Fort Worth, Texas, United States
Unknown Facility
San Antonio, Texas, United States
Unknown Facility
Falls Church, Virginia, United States
Unknown Facility
Milwaukee, Wisconsin, United States
Unknown Facility
Kingston, Ontario, Canada
Unknown Facility
Trois-Rivières, Quebec, Canada
Related Publications (1)
Williamson BD, Gohn DC, Ramza BM, Singh B, Zhong Y, Li S, Shanahan L; SureScan Post-Approval Study Investigators. Real-World Evaluation of Magnetic Resonance Imaging in Patients With a Magnetic Resonance Imaging Conditional Pacemaker System: Results of 4-Year Prospective Follow-Up in 2,629 Patients. JACC Clin Electrophysiol. 2017 Nov;3(11):1231-1239. doi: 10.1016/j.jacep.2017.05.011. Epub 2017 Sep 13.
PMID: 29759618DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2011
First Posted
February 18, 2011
Study Start
February 8, 2011
Primary Completion
October 2, 2017
Study Completion
October 2, 2017
Last Updated
April 27, 2018
Record last verified: 2018-04